Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How does amniotic membrane work?

Scheffer C G Tseng1, Edgar M Espana, Tetsuya Kawakita

  • 1Ocular Surface Center and TissueTech, Inc., Miami, Florida 33173, USA. stseng@ocularsurface.com

The Ocular Surface
|January 12, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased Risk for Ocular Surface Neoplasia in Recipients of Solid Organ Transplant.

American journal of ophthalmology·2026
Same author

Generation of a Novel Col8a2<sup>P2A-CreERT2</sup> Mouse Line Enables Targeted Genetic Manipulation of Corneal Endothelial Cells and Modeling of Endothelial Decompensation.

Genesis (New York, N.Y. : 2000)·2026
Same author

Keratocyte Depletion by Genetic Manipulation Re-creates Corneal Ectasia in a Mouse Model.

The American journal of pathology·2026
Same author

Latent-Transforming growth factor - β Binding protein 1 (LTBP1) in corneal stroma.

Matrix biology plus·2025
Same author

Co-delivery of ripasudil and dexamethasone in trabecular meshwork cells for potential prevention of GC-induced ocular hypertension.

Experimental cell research·2025
Same author

Topical duloxetine for treatment of corneal keratinization in Aniridia-Associated Keratopathy.

The ocular surface·2025

Amniotic membrane transplantation promotes ocular surface healing and reduces scarring by mimicking an in utero environment. This regenerative approach also supports progenitor cell expansion for tissue engineering applications.

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Tissue Engineering

Background:

  • The amniotic membrane is utilized as a graft for ocular surface reconstruction.
  • Its therapeutic effects stem from anti-inflammatory and anti-scarring properties.
  • These actions are linked to the preparation method preserving the extracellular matrix and eliminating allogeneic cells.

Purpose of the Study:

  • To review the mechanisms of amniotic membrane transplantation in promoting ocular wound healing.
  • To explore its role as a niche for progenitor cell expansion and tissue engineering.
  • To highlight potential future applications in regenerative medicine.

Main Methods:

  • Review of existing literature on amniotic membrane transplantation.
  • Analysis of the in utero functions of the amniotic membrane.

Related Experiment Videos

  • Evaluation of ex vivo progenitor cell expansion on amniotic membrane scaffolds.

    • Main Results:

    • Amniotic membrane transplantation effectively promotes epithelial wound healing and reduces inflammation and scarring on the ocular surface.
    • The preparation method is crucial for preserving therapeutic factors and eliminating immunogenic cells.
    • The amniotic membrane serves as an ideal substrate for expanding epithelial and mesenchymal progenitor cells ex vivo.
    • These expanded cells maintain their normal phenotypes, making them suitable for tissue engineering.

    Conclusions:

    • Amniotic membrane transplantation recreates a protective fetal environment, enhancing ocular surface repair.
    • The amniotic membrane is a promising substrate for engineering ocular surface tissues for transplantation.
    • Further research into its molecular mechanisms may reveal broader applications in regenerative medicine for both ocular and nonocular tissues.